CC chemokine ligand 1 is released into the airways of atopic asthmatics

European Respiratory Journal

Volumn 28, Issue 1, 2006, Pages 59-67

  Montes Vizuet, R ^a   Vega Miranda, A ^a   Valencia Maqueda, E ^a   Negrete Garcia M C ^a   Velasquez J R ^b   Teran, L M ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Asthma; Bronchoalveolar lavage fluid; CC chemokine ligand l 309; Lymhocytes

Indexed keywords

BETA CHEMOKINE; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4;

ADULT; AFFINITY CHROMATOGRAPHY; ALLERGIC ASTHMA; ARTICLE; CD4+ T LYMPHOCYTE; CELL STIMULATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG LAVAGE; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESPIRATORY EPITHELIUM; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TH2 CELL; WESTERN BLOTTING;

ADOLESCENT; ADULT; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES, CC; CYTOKINES; EOSINOPHILS; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; INTERLEUKIN-4; MALE; MIDDLE AGED;

EID: 33845504304     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00134304     Document Type: Article

References (46)

1. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB. Interleukins-4 -5 and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther 2002; 94: 253-264.
2. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992; 326: 298-304.
3. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993; 8: 35-42.
4. Del Prete GF, De Carli M, D'Elios MM, et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993; 23: 1445-1449.
5. Bodey KJ, Semper AE, Redington AE, et al. Cytokine profiles of BAL T-cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 1999; 54: 1083-1093.
6. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12: 121-127.
7. Teran LM. CCL chemokines and asthma. Immunol Today 2000; 21: 235-242.
8. Miller MD, Hata S, De Waal Malefyt R, Krangel MS. A novel polypeptide secreted by activated human T lymphocytes. J Immunol 1989; 143: 2907-2916.
9. Miller MD, Krangel MS. The human cytokine I-309 is a monocyte chemoattractant. Proc Natl Acad Sci USA 1992; 89: 2950-2954.
10. D'Ambrosio D, Iellem A, Bonecchi R, et al. Selective upregulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. J Immunol 1998; 161: 5111-5115.
11. Zingoni A, Soto H, Hedrick JA, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998; 161: 547-551.
12. Miller MD, Wilson SD, Dorf ME, Seuanez HN, O'Brien SJ, Krangel MS. Sequence and chromosomal location of the I-309 gene. Relationship to genes encoding a family of inflammatory cytokines. J Immunol 1990; 145: 2737-2744.
13. Selvan RS, Zhou LJ, Krangel MS. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol 1997; 27: 687-694.
14. Haque NS, Zhang X, French DL, et al. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation 2000; 102: 786-792.
15. Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, Moser B. Identification of CCR8, the receptor for the human CC chemokine I-309. J Biol Chem 1997; 272: 17251-17254.
16. Tiffany HL, Lautens LL, Gao JL, et al. Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309. J Exp Med 1997; 186: 165-170.
17. Panina-Bordignon P, Papi A, Mariani M, et al. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest 2001; 107: 1357-1364.
18. Bochner BS, Hudson SA, Xiao HQ, Liu MC. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 2003; 112: 930-934.
19. Lezcano-Meza D, Negrete-Garcia C, Dante-Escobedo M, Teran LM. The monocyte derived chemokine (MDC) is released into the bronchoalveolar lavage fluid of steady state asthmatics. Allergy 2003; 58: 1125-1130.
20. Bishop B, Lloyd CM. CC chemokine ligand 1 promotes recruitment of eosinophils but not Th2 cells during the development of allergic airway disease. J Immunol 2003; 170: 4810-4817.
21. Chensue SW, Lukacs NW, Yang TY, et al. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J Exp Med 2001; 193: 573-584.
22. Chung CD, Kuo F, Kumer J, et al. CCR8 is not essential for the development of inflammation in a mouse model of allergic airway disease. J Immunol 2003; 170: 581-587.
23. National Heart, Lung and Blood Institute. Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma. J Allergy Clin Immunol 1991; 88: 808-814.
24. Harder J, Meyer-Hoffert U, Teran LM, et al. Mucoid pseudomonas aeruginosa, TNF-alpha, and IL-1 beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000; 22: 714-721.
25. Teran LM, Noso N, Carroll M, Davies DE, Holgate ST, Schröder JM. Eosinophil recruitment following endobronchial allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996; 157: 1806-1812.
26. Colantonio L, Recalde H, Sinigaglia F, D'Ambrosio D. Modulation of chemokine receptor expression and chemotactic responsiveness during differentiation of human naive T cells into Th1 and Th2 cells. Eur J Immunol 2002; 32: 1264-1273.
27. Teran LM, Campos MG, Begishvilli BT, et al. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 1997; 27: 396-405.
28. Synek M, Beasley R, Frew AJ, et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154: 224-230.
29. Velazquez JR, Lacy P, Moqbel R. Replenishment of RANTES mRNA expression in activated eosinophils from atopic asthmatics. Immunology 2000; 99: 591-599.
30. Burd PR, Freeman GJ, Wilson SD, et al. Cloning and characterization of a novel T cell activation gene. J Immunol 1987; 139: 3126-3131.
31. Goya I, Gutierrez J, Varona R, Kremer L, Zaballos A, Marquez G. Identification of the CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3. J Immunol 1998; 160: 1975-1981.
32. Scheerens H, Hessel E, de Waal-Malefyt R, Leach MW, Rennick D. Characterization of the chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/-mice and Rag-2-/-mice reconstituted with CD4+CD45RBhigh T cells. Eur J Immunol 2001; 31: 1465-1474.
33. Teuscher C, Butterfield RJ, Ma RZ, Zachary JF, Doerge RW, Blankenhorn EP. Sequence polymorphism in the chemokines Scyal (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1) and Scyal2 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental encephalomyelitis. J Immunol 1999; 163: 2262-2266.
34. Jones KP, Edwards JH, Reynolds SP, Peters TJ, Davies BH. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease. Eur Respir J 1990; 3: 152-156.
35. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithlelial lining fluid recovered by lavage using urea as marker of dillution. J Appl Physiol 1986; 60: 532-538.
36. Marcy TW, Merrill WW, Rankin JA, Reynolds HY. Limitations of using urea to quantify epithelial lining fluid recovered by bronchoalveolar lavage. Am Rev Respir Dis 1987; 135: 1276-1280.
37. Lilly CM, Nakamura H, Belostotsky OI, et al. Eotaxin expression after segmental allergen challenge in subjects with atopic asthma. Am J Respir Crit Care Med 2001; 163: 1669-1675.
38. Lezcano Meza D, Negrete Garcia MC, Montes Vizuet A, et al. La quimiocina regulada y activada del timo (TARC) se libera en las vías aéreas de pacientes asmáticos. [The chemokine thymus- and activation-regulated chemokine (TARC) is released into the airways of asthmatic patients.] Rev Inst Nal Enf Resp Mex 2002; 115: 201-205.
39. Holgate ST, Bodey KS, Janezic A, Frew AJ, Kaplan AP, Teran LM. Release of RANTES, MIP-1 alpha and MCP-1 into asthmatic airways following endobronchial allergen challenge. Am J Respir Crit Care Med 1997; 156: 1377-1383.
40. Oddera S, Silvestri M, Galeazzi G, Crimi E, Rossi GA. Airway eosinophilic inflammation and bronchial hyperresponsiveness after allergen inhalation challenge in asthma. Lung 1998; 176: 237-247.
41. Wilson DR, Merrett TG, Varga EM, et al. Increases in allergen-specific IgE in BAL after segmental challenge in atopic asthmatics. Am J Respir Crit Care Med 2002; 165: 22-26.
42. Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-248.
43. Ryan JJ. Interleukin-4 and its receptor: Essential mediators of the allergic response. J Allergy Clin Immunol 1997; 99: 1-5.
44. Brombacher F. The role of interleukin-13 in infectious diseases and allergy. Bioessays 2000; 22: 646-656.
45. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12: 477-487.
46. Schaerli P, Ebert L, William K, et al. A skin-selective homing mechanism for human surveillance T cells. J Exp Med 2004; 199: 1265-1275.